Shockwave Medical, Inc.

Shockwave Medical, Inc. (SWAV) priced its initial public offering on Mar 8, 2019 at $17.00 per share, raising $96.9M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $457.4M. Davis Polk advised the company and Cooley advised the underwriters.

Shockwave Medical, Inc. is a medical device company treating calcified cardiovascular disease with intravascular lithotripsy, which delivers sonic pressure waves locally to break up calcified plaque. Its M5 catheter is cleared in the U.S. for peripheral artery disease, and it also markets a C2 catheter.

Status

IPO

Ticker

SWAV

Exchange

Nasdaq Global Select

Priced

Mar 8, 2019

IPO price

$17.00

Raised

$96.9M

Market cap at IPO price

$457.4M

First filed

Feb 8, 2019

Company counsel

Davis Polk

Underwriters' counsel

Cooley

Sector

Healthcare

Country / state

CA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.